November 9, 2021

The FDA released a Form 483 inspection report based on twenty-one site inspections of Philips’s Murrysville, Pennsylvania manufacturing facility between August 26, 2021 and November 9, 2021. The report concluded that Philips knew about the foam degradation issues since 2015, but never completed a health hazard evaluation, risk analysis, or design review prior to the recall.